Emerging Trends in Oncolytic Virus Therapy

Oncolytic virus therapy is an innovative cancer treatment that uses genetically modified viruses to selectively infect and kill cancer cells. These viruses are designed to replicate within tumor cells, causing cell lysis while sparing healthy cells. Additionally, oncolytic viruses can stimulate the immune system to recognize and attack cancer cells, providing an added therapeutic benefit. Emerging trends in oncolytic virus therapy focus on improving viral selectivity, enhancing immune responses, and combining the therapy with other cancer treatments, such as immune checkpoint inhibitors. This promising treatment has shown potential in clinical trials, with several viruses demonstrating efficacy against various types of cancer. Ongoing research aims to optimize these therapies and expand their clinical applications.